Neonatal hyperbilirubinemia after treatment of maternal leprosy.
Leprosy occurs rarely in women of reproductive age. Until this report, the treatment of leprosy with dapsone has not been associated with any adverse fetal or neonatal side effects. We have reported what we believe to be the first case of neonatal hyperbilirubinemia after maternal dapsone therapy for leprosy.
Thornton
Y S
YS
Sloane Hospital for Women, Division of Perinatal Obstetrics, New York, NY.
Bowe
E T
ET
D000328:Adult; D003622:Dapsone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000139:chemically induced*; D015441:Leprosy, Tuberculoid / Q000188:drug therapy*; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*
D003622:Dapsone